Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;11(2):65-72.
doi: 10.1007/BF02888091.

[Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats]

[Article in German]
Affiliations

[Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats]

[Article in German]
A P Zou et al. J Tongji Med Univ. 1991.

Abstract

Anisodamine is an alkaloid extracted from the Tibetan plant "Anisodus tanguticus". Since 1965 it has been used in China for the treatment of shock but the mechanisms of its action are not fully known. The present study was performed to determine the effect of anisodamine on the renal microcirculation and to examine the underlying mechanism of its actions. The addition of anisodamine (10(-8) M to 10(-3) M) to the kidney bath resulted in a significant and dose dependent dilation of all preglomerular vessels. The maximal dilation (about 30% dilation) was found in the proximal interlobular artery. In contrast to preglomerular vessels anisodamine caused constriction of postglomerular vessels. The glomerular blood flow increased by about 50% at anisodamine concentration of 10(-3) M. Haloperidol, a dopamine receptor antagonist could abolish the renal vascular effect of anisodamine. It is suggested that anisodamine could improve renal function by the dilation of preglomerular vessels in combination with the constriction of postglomerular vessels, and the effect of anisodamine may be mediated by activation of the dopaminergic system.

PubMed Disclaimer

Similar articles

References

    1. Nature. 1986 Dec 4-10;324(6096):473-6 - PubMed
    1. Microvasc Res. 1975 Sep;10(2):165-79 - PubMed
    1. J Pharmacol Exp Ther. 1969 Aug;168(2):303-9 - PubMed
    1. Kidney Int. 1981 Feb;19(2):306-16 - PubMed
    1. Am J Med. 1984 Apr;76(4):702-10 - PubMed

Publication types

MeSH terms